摘要
目的分析急性脑梗死患者选择疏血通联合依达拉奉治疗的效果。方法方便选择急性脑梗死患者72例,选择时间:2015年2月—2018年2月,分别行不同的治疗方式:疏血通治疗、疏血通联合依达拉奉治疗,对应组别:对照组、观察组。对比2组临床疗效、NHISS评分、ADL评分、不良反应发生情况。结果 (1)观察组显效例数有30例,对照组为21例,差异有统计学意义(χ2=5.445 4、P=0.019 6);(2)观察组治疗后NHISS评分为(8.54±2.22)分、ADL评分为(51.25±6.98)分,数据与对照组数据之间进行比较,差异有统计学意义(t=2.589 7、P=0.011 7;t=5.579 3、P=0.000 1);(3)观察组不良反应例数有2例,对照组数据为13例,对照组数据明显高于观察组(χ2=10.189 5、P=0.001 4)。结论疏血通联合依达拉奉治疗急性脑梗死疗效较为确切,可有效改善患者的临床症状,不良反应发生率较低,安全有效,可推广。
Objective To analyze the effect of Shuxuetong combined with edaravone in patients with acute cerebral infarction.Methods 72 patients with acute cerebral infarction were convenient selected.The selection time was from February 2015 to February 2018.Different treatment methods were used:Shuxuetong treatment,Shuxuetong combined with edaravone treatment,divided into the control group,observation group.The clinical efficacy,NHISS score,ADL score,and adverse reactions of the two groups were compared.Results 1.There were 30 cases in the observation group and 21 cases in the control group.The difference was statistically significant(χ^2=5.445 4、P=0.019 6).2.The NHISS score of the observation group was(8.54±2.22)points and the ADL score was(51.25±6.98)points,the data were compared with the control data,the difference was significant,(t=2.589 7,P=0.011 7;t=5.579 3,P=0.000 1);3.observation group adverse reaction number 2 cases,the data of the control group were 13 cases,and the data of the control group was significantly higher than that of the observation group.(χ^2=0.189 5,P=0.001 4).Conclusion Shuxuetong combined with edaravone is effective in the treatment of acute cerebral infarction,which can effectively improve the clinical symptoms of patients,and the incidence of adverse reactions is low,safe and effective,and can be promoted.
作者
梁海峰
杜守云
薛晓琳
刘敏华
李国栋
LIANG Hai-feng;DU Shou-yun;XUE Xiao-lin;LIU Min-hua;LI Guo-dong(Emergency Department,Guanyun County People's Hospital,Lianyungang,Jiangsu Province,222200 China;Internal Medicine,Guanyun County People's Hospital,Lianyungang,Jiangsu Province,222200 China)
出处
《中外医疗》
2019年第1期101-102,141,共3页
China & Foreign Medical Treatment
关键词
疏血通
依达拉奉
急性脑梗死
临床效果
分析
Shuxuetong
Edaravone
Acute cerebral infarction
Clinical effect
Analysis
